Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin

Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods Given...

Full description

Saved in:
Bibliographic Details
Published inJournal of cancer research and clinical oncology Vol. 138; no. 1; pp. 23 - 33
Main Authors Orozco-Morales, Mario, Sánchez-García, Francisco-Javier, Guevara-Salazar, Patricia, Arrieta, Oscar, Hernández-Pedro, Norma Y., Sánchez-García, Aurora, Perez-Madrigal, Rodolfo, Rangel-López, Edgar, Pineda, Benjamín, Sotelo, Julio
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.01.2012
Springer
Springer Nature B.V
Subjects
Rat
Online AccessGet full text

Cover

Loading…
Abstract Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. Results We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. Conclusion These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.
AbstractList In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.
Purpose: In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods: Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. Results: We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1 alpha . Conclusion: These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.
In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.PURPOSEIn spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.METHODSGiven the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.RESULTSWe observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.CONCLUSIONThese results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.
In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.[PUBLICATION ABSTRACT]
Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. Results We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. Conclusion These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.
Author Sánchez-García, Francisco-Javier
Hernández-Pedro, Norma Y.
Sánchez-García, Aurora
Guevara-Salazar, Patricia
Sotelo, Julio
Rangel-López, Edgar
Orozco-Morales, Mario
Pineda, Benjamín
Perez-Madrigal, Rodolfo
Arrieta, Oscar
Author_xml – sequence: 1
  givenname: Mario
  surname: Orozco-Morales
  fullname: Orozco-Morales, Mario
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN), Immunoregulation Unit from Instituto Politecnico Nacional
– sequence: 2
  givenname: Francisco-Javier
  surname: Sánchez-García
  fullname: Sánchez-García, Francisco-Javier
  organization: Immunoregulation Unit from Instituto Politecnico Nacional
– sequence: 3
  givenname: Patricia
  surname: Guevara-Salazar
  fullname: Guevara-Salazar, Patricia
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
– sequence: 4
  givenname: Oscar
  surname: Arrieta
  fullname: Arrieta, Oscar
  organization: Laboratory of Experimental Oncology, Instituto Nacional de Cancerologia (INCan)
– sequence: 5
  givenname: Norma Y.
  surname: Hernández-Pedro
  fullname: Hernández-Pedro, Norma Y.
  organization: Laboratory of Experimental Oncology, Instituto Nacional de Cancerologia (INCan)
– sequence: 6
  givenname: Aurora
  surname: Sánchez-García
  fullname: Sánchez-García, Aurora
  organization: Pathology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
– sequence: 7
  givenname: Rodolfo
  surname: Perez-Madrigal
  fullname: Perez-Madrigal, Rodolfo
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
– sequence: 8
  givenname: Edgar
  surname: Rangel-López
  fullname: Rangel-López, Edgar
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
– sequence: 9
  givenname: Benjamín
  surname: Pineda
  fullname: Pineda, Benjamín
  email: benpio76@hotmail.com
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
– sequence: 10
  givenname: Julio
  surname: Sotelo
  fullname: Sotelo, Julio
  organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN)
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25566359$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21947268$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhS1URKcDP4ANipAQbFL8drwq1YhHpUpsYG05jjPjUWIPtlOYf4-jmdKHRFeWfb9zdO71PQMnPngLwGsEzxGE4mOCkBJcQ4RqBLms98_AAs0viBB2AhYQCVQzjPgpOEtpC8udCfwCnGIkqcC8WYBPl912utE-V24cJx_yxka921ehr1a8Wg8ujLpyvoo6p-q3y5tqZ2OeUnKpyuGP8y_B814Pyb46nkvw88vnH6tv9fX3r1ery-vaMIJzjZgkrBVIGmgkNj0VpsWawV5L3beypawjvZWUc2uhNVBqIVjfNoIh0zUdJ0twcfDdTe1oO2N9jnpQu-hGHfcqaKceVrzbqHW4UQg1mJZ-i8P7o0MMvyabshpdMnYYtLdhSkoiQikXFBfyw5NkGX7TEEgxLOjbR-g2TNGXScx-SPCGkAK9uZ_9X-jbbyjAuyOgk9FDH7U3Lt1xjHFOygSXQBw4E0NK0fbKuKyzC3PLbijB5mxCHRZDlcVQ82KofVGiR8pb86c0-KBJhfVrG-96-7_oL9n2yiw
CODEN JCROD7
CitedBy_id crossref_primary_10_1371_journal_pone_0168418
crossref_primary_10_1186_s40659_016_0067_6
crossref_primary_10_3390_toxins13080565
crossref_primary_10_1038_s41598_017_17752_w
crossref_primary_10_1080_14760584_2017_1306440
crossref_primary_10_1515_revneuro_2023_0067
crossref_primary_10_1155_2013_716813
crossref_primary_10_18632_oncotarget_16214
crossref_primary_10_1155_2016_7487313
crossref_primary_10_1002_ijc_28858
crossref_primary_10_1007_s00432_013_1565_3
crossref_primary_10_2217_fmb_14_123
crossref_primary_10_3389_fmicb_2018_00783
Cites_doi 10.1158/0008-5472.CAN-05-3773
10.3171/foc.2006.20.4.E1
10.1385/IR:32:1-3:155
10.1073/pnas.82.9.2637
10.1023/A:1006112422132
10.1038/nm1093
10.1126/science.161.3839.370
10.1111/j.1600-0897.2005.00330.x
10.1084/jem.182.2.581
10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1
10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W
10.1136/jcp.54.9.669
10.1007/s11060-006-9314-y
10.1002/jcp.10290
10.1084/jem.191.9.1605
10.1016/0008-8749(84)90228-4
10.3171/jns.2006.105.3.430
10.1016/S0959-8049(98)00244-5
10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H
10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B
10.1093/intimm/10.5.651
10.1056/NEJMoa043330
10.1215/15228517-2006-006
10.1016/S0165-5728(02)00203-5
10.1242/jcs.00378
10.1016/S0090-3019(99)00177-9
10.1084/jem.156.1.31
10.1002/eji.200535353
10.1007/s00262-005-0699-9
10.1046/j.1462-5822.2001.00106.x
10.1053/j.seminoncol.2003.11.031
10.1097/00005072-198709000-00001
10.1016/S0171-2985(11)80001-X
10.1161/ATVBAHA.107.159160
10.1128/IAI.59.12.4732-4734.1991
10.4049/jimmunol.177.3.1552
10.4049/jimmunol.170.4.1728
10.4049/jimmunol.178.10.6123
10.4049/jimmunol.130.6.2675
10.4049/jimmunol.169.1.117
10.4049/jimmunol.173.1.92
10.1007/s11060-004-3339-x
10.7785/tcrt.2012.500183
10.1007/BF00300234
10.5858/2003-127-187-CHCOTO
10.4049/jimmunol.163.10.5211
10.4049/jimmunol.170.3.1504
10.4049/jimmunol.169.5.2756
ContentType Journal Article
Copyright Springer-Verlag 2011
2015 INIST-CNRS
Springer-Verlag 2012
Springer-Verlag 2011 2011
Copyright_xml – notice: Springer-Verlag 2011
– notice: 2015 INIST-CNRS
– notice: Springer-Verlag 2012
– notice: Springer-Verlag 2011 2011
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7T5
7X8
5PM
DOI 10.1007/s00432-011-1069-y
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Immunology Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts
MEDLINE - Academic
Research Library Prep

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1335
EndPage 33
ExternalDocumentID PMC11824194
2550858641
21947268
25566359
10_1007_s00432_011_1069_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
-~X
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8C1
8FI
8FJ
8G5
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAHNG
AAIAL
AAJKR
AAJSJ
AAKKN
AANXM
AANZL
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABEEZ
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMOR
ABMQK
ABNWP
ABPLI
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACACY
ACBXY
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACUDM
ACULB
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFGXO
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C24
C6C
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GROUPED_DOAJ
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAFWJ
AASML
AAYXX
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFHIU
AFPKN
AGQPQ
AHPBZ
AHWEU
AIXLP
AYFIA
CITATION
PHGZM
PHGZT
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7XB
8FK
H94
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
RPM
7T5
7X8
5PM
ID FETCH-LOGICAL-c532t-15935b719c0c92cf47cb2a50fa9afb9b45d3fe9466ee0ec09a775fb8751cd8d63
IEDL.DBID 7X7
ISSN 0171-5216
1432-1335
IngestDate Thu Aug 21 18:24:37 EDT 2025
Tue Aug 05 11:29:28 EDT 2025
Thu Jul 10 19:55:14 EDT 2025
Fri Aug 15 20:04:26 EDT 2025
Sun Jul 20 01:30:37 EDT 2025
Mon Jul 21 09:14:39 EDT 2025
Tue Jul 01 02:28:29 EDT 2025
Thu Apr 24 22:51:42 EDT 2025
Fri Feb 21 02:26:28 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords C6 glioma
Regulatory T cells
Glioblastoma multiforme
Pertussis toxin
Immunotherapeutic
Nervous system diseases
Rat
Rodentia
Adjuvant treatment
Malignant tumor
Malignant glioma
Vertebrata
Mammalia
Animal
Immunotherapy
Central nervous system disease
T-Lymphocyte
Regulatory cell
Cancer
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-15935b719c0c92cf47cb2a50fa9afb9b45d3fe9466ee0ec09a775fb8751cd8d63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/11824194
PMID 21947268
PQID 913176833
PQPubID 47182
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11824194
proquest_miscellaneous_913446742
proquest_miscellaneous_1008830420
proquest_journals_913176833
pubmed_primary_21947268
pascalfrancis_primary_25566359
crossref_citationtrail_10_1007_s00432_011_1069_y
crossref_primary_10_1007_s00432_011_1069_y
springer_journals_10_1007_s00432_011_1069_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
– name: Germany
PublicationTitle Journal of cancer research and clinical oncology
PublicationTitleAbbrev J Cancer Res Clin Oncol
PublicationTitleAlternate J Cancer Res Clin Oncol
PublicationYear 2012
Publisher Springer-Verlag
Springer
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer
– name: Springer Nature B.V
References Tonon, Goriely, Aksoy, Pradier, Del Giudice, Trannoy, Willems, Goldman, De Wit (CR48) 2002; 32
Shimizu, Yamazaki, Sakaguchi (CR44) 1999; 163
Curiel, Coukos, Zou, Alvarez, Cheng, Mottram, Evdemon-Hogan, Conejo-Garcia, Zhang, Burow, Zhu, Wei, Kryczek, Daniel, Gordon, Myers, Lackner, Disis, Knutson, Chen, Zou (CR13) 2004; 10
Linthicum (CR32) 1982; 162
Ryan, McCarthy, Rappuoli, Mahon, Mills (CR43) 1998; 10
Garcia-Lora, Algarra, Garrido (CR21) 2003; 195
Linehan, Goedegebuure (CR31) 2005; 32
Darabi, Karulin, Boehm, Hofstetter, Fabry, LaManna, Chavez, Tary-Lehmann, Lehmann (CR15) 2004; 173
Onizuka, Tawara, Shimizu, Sakaguchi, Fujita, Nakayama (CR40) 1999; 59
Nencioni, Pizza, Volpini, De Magistris, Giovannoni, Rappuoli (CR39) 1991; 59
Buckner (CR8) 2003; 30
Hart, Linthicum, Waldschmidt, Tassell, Schelper, Robinson (CR24) 1987; 46
Liyanage, Moore, Joo, Tanaka, Herrmann, Doherty, Drebin, Strasberg, Eberlein, Goedegebuure, Linehan (CR34) 2002; 169
Linthicum, Frelinger (CR33) 1982; 156
Ichihara, Kono, Takahashi, Kawaida, Sugai, Fujii (CR28) 2003; 9
El Andaloussi, Lesniak (CR18) 2007; 83
Stupp, Mason, van den Bent, Weller, Fisher, Taphoorn, Belanger, Brandes, Marosi, Bogdahn, Curschmann, Janzer, Ludwin, Gorlia, Allgeier, Lacombe, Cairncross, Eisenhauer, Mirimanoff (CR47) 2005; 352
Agarwal, Sun, Su, Chan, Caspi (CR1) 2002; 129
Chen, Winkler-Pickett, Carbonetti, Ortaldo, Oppenheim, Howard (CR11) 2006; 36
Woo, Chu, Goletz, Schlienger, Yeh, Coukos, Rubin, Kaiser, June (CR50) 2001; 61
Chattopadhyay, Chakraborty, Mukherji (CR10) 2005; 54
Cassan, Piaggio, Zappulla, Mars, Couturier, Bucciarelli, Desbois, Bauer, Gonzalez-Dunia, Liblau (CR9) 2006; 177
Guevara, Sotelo (CR23) 1999; 44
Pineda, Estrada-Parra, Pedraza-Medina, Rodriguez-Ropon, Perez, Arrieta (CR42) 2005; 24
Zhu, Lu, Xiao, Qiao, Sun (CR53) 2005; 74
Backlund, Meade, Manclark, Cantoni, Aksamit (CR4) 1985; 82
Lopez-Gonzalez, Sotelo (CR35) 2000; 53
He, Gurunathan, Iwasaki, Ash-Shaheed, Kelsall (CR25) 2000; 191
Mielcarek, Hornquist, Johansson, Locht, Abraham, Holmgren (CR37) 2001; 3
Hou, Wu, Sun, Shi, Sun, Yang, Pei, Gu, Zhong, Sun (CR27) 2003; 170
Jager, Jager, Knuth (CR29) 2001; 54
Arrieta, Guevara, Reyes, Ortiz, Rembao, Sotelo (CR3) 1998; 34
Munoz, Bernard, Mackay (CR38) 1984; 83
Bruckener, el Baya, Galla, Schmidt (CR7) 2003; 116
Velasquez-Perez, Jimenez-Marcial (CR49) 2003; 127
Golgher, Jones, Powrie, Elliott, Gallimore (CR22) 2002; 32
Mascart, Verscheure, Malfroot, Hainaut, Pierard, Temerman, Peltier, Debrie, Levy, Del Giudice, Locht (CR36) 2003; 170
El Andaloussi, Han, Lesniak (CR19) 2006; 105
Shive, Hofstetter, Arredondo, Shaw, Forsthuber (CR45) 2000; 30
El Andaloussi, Lesniak (CR17) 2006; 8
Barnett, Kryczek, Cheng, Zou, Curiel (CR5) 2005; 54
Fecci, Mitchell, Whitesides, Xie, Friedman, Archer, Herndon, Bigner, Dranoff, Sampson (CR20) 2006; 66
Alt, Laschinger, Engelhardt (CR2) 2002; 32
Li, Liu, Zhang, Zhou, Guo, Chen, Ke, Jiang, Cai (CR52) 2011; 10
Tomayko, Reynolds (CR51) 1989; 24
Hofstetter, Shive, Forsthuber (CR26) 2002; 169
Strojnik, Kavalar, Zajc, Diamandis, Oikonomopoulou, Lah (CR46) 2009; 29
Cyster, Goodnow (CR14) 1995; 182
Chen, Howard, Oppenheim (CR12) 2007; 178
Kohno, Munoz, Williams, Teuscher, Bernard, Tung (CR30) 1983; 130
Benda, Lightbody, Sato, Levine, Sweet (CR6) 1968; 161
Papaspyridonos, McNeill, de Bono, Smith, Burnand, Channon, Greaves (CR41) 2008; 28
Deorah, Lynch, Sibenaller, Ryken (CR16) 2006; 20
EY Woo (1069_CR50) 2001; 61
D Golgher (1069_CR22) 2002; 32
MN Hart (1069_CR24) 1987; 46
MA Lopez-Gonzalez (1069_CR35) 2000; 53
R Stupp (1069_CR47) 2005; 352
JG Cyster (1069_CR14) 1995; 182
M Ryan (1069_CR43) 1998; 10
A El Andaloussi (1069_CR18) 2007; 83
B Pineda (1069_CR42) 2005; 24
L Nencioni (1069_CR39) 1991; 59
PS Backlund Jr (1069_CR4) 1985; 82
J He (1069_CR25) 2000; 191
K Darabi (1069_CR15) 2004; 173
P Guevara (1069_CR23) 1999; 44
KE Bruckener (1069_CR7) 2003; 116
F Ichihara (1069_CR28) 2003; 9
S Deorah (1069_CR16) 2006; 20
HH Hofstetter (1069_CR26) 2002; 169
W Hou (1069_CR27) 2003; 170
DS Linthicum (1069_CR33) 1982; 156
A El Andaloussi (1069_CR17) 2006; 8
DC Linehan (1069_CR31) 2005; 32
PE Fecci (1069_CR20) 2006; 66
C Alt (1069_CR2) 2002; 32
X Chen (1069_CR11) 2006; 36
T Strojnik (1069_CR46) 2009; 29
S Onizuka (1069_CR40) 1999; 59
C Cassan (1069_CR9) 2006; 177
B Barnett (1069_CR5) 2005; 54
X Chen (1069_CR12) 2007; 178
M Papaspyridonos (1069_CR41) 2008; 28
JC Buckner (1069_CR8) 2003; 30
S Chattopadhyay (1069_CR10) 2005; 54
1069_CR51
1069_CR52
1069_CR53
JJ Munoz (1069_CR38) 1984; 83
CL Shive (1069_CR45) 2000; 30
O Arrieta (1069_CR3) 1998; 34
UK Liyanage (1069_CR34) 2002; 169
S Kohno (1069_CR30) 1983; 130
DS Linthicum (1069_CR32) 1982; 162
L Velasquez-Perez (1069_CR49) 2003; 127
N Mielcarek (1069_CR37) 2001; 3
RK Agarwal (1069_CR1) 2002; 129
P Benda (1069_CR6) 1968; 161
F Mascart (1069_CR36) 2003; 170
D Jager (1069_CR29) 2001; 54
A El Andaloussi (1069_CR19) 2006; 105
J Shimizu (1069_CR44) 1999; 163
A Garcia-Lora (1069_CR21) 2003; 195
S Tonon (1069_CR48) 2002; 32
TJ Curiel (1069_CR13) 2004; 10
References_xml – volume: 170
  start-page: 1728
  year: 2003
  end-page: 1736
  ident: CR27
  article-title: Pertussis toxin enhances Th1 responses by stimulation of dendritic cells
  publication-title: J Immunol
– volume: 66
  start-page: 3294
  year: 2006
  end-page: 3302
  ident: CR20
  article-title: Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3773
– volume: 163
  start-page: 5211
  year: 1999
  end-page: 5218
  ident: CR44
  article-title: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity
  publication-title: J Immunol
– volume: 24
  start-page: 575
  year: 2005
  end-page: 583
  ident: CR42
  article-title: Interstitial transfer factor as adjuvant immunotherapy for experimental glioma
  publication-title: J Exp Clin Cancer Res
– volume: 20
  start-page: E1
  year: 2006
  ident: CR16
  article-title: Trends in brain cancer incidence, survival in the United States: Surveillance, Epidemiology, End Results Program, 1973 to 2001
  publication-title: Neurosurg Focus
  doi: 10.3171/foc.2006.20.4.E1
– volume: 130
  start-page: 2675
  year: 1983
  end-page: 2682
  ident: CR30
  article-title: Immunopathology of murine experimental allergic orchitis
  publication-title: J Immunol
– volume: 32
  start-page: 155
  year: 2005
  end-page: 168
  ident: CR31
  article-title: CD25+CD4+ regulatory T-cells in cancer
  publication-title: Immunol Res
  doi: 10.1385/IR:32:1-3:155
– volume: 82
  start-page: 2637
  year: 1985
  end-page: 2641
  ident: CR4
  article-title: Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.82.9.2637
– volume: 44
  start-page: 91
  year: 1999
  end-page: 92
  ident: CR23
  article-title: C6 rat glioma grown into the peritoneal cavity, a large source of tumoral cells for subcutaneous transplant of glioma
  publication-title: J Neurooncol
  doi: 10.1023/A:1006112422132
– volume: 169
  start-page: 117
  year: 2002
  end-page: 125
  ident: CR26
  article-title: Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund’s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells
  publication-title: J Immunol
– volume: 10
  start-page: 942
  year: 2004
  end-page: 949
  ident: CR13
  article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
  publication-title: Nat Med
  doi: 10.1038/nm1093
– volume: 24
  start-page: 148
  year: 1989
  end-page: 154
  ident: CR51
  article-title: Determination of subcutaneous tumor size in athymic (nude) mice
  publication-title: Cancer Chemother Pharmacol
– volume: 59
  start-page: 3128
  year: 1999
  end-page: 3133
  ident: CR40
  article-title: Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody
  publication-title: Cancer Res
– volume: 161
  start-page: 370
  year: 1968
  end-page: 371
  ident: CR6
  article-title: Differentiated rat glial cell strain in tissue culture
  publication-title: Science
  doi: 10.1126/science.161.3839.370
– volume: 170
  start-page: 1504
  year: 2003
  end-page: 1509
  ident: CR36
  article-title: Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses
  publication-title: J Immunol
– volume: 59
  start-page: 4732
  year: 1991
  end-page: 4734
  ident: CR39
  article-title: Properties of the B oligomer of pertussis toxin
  publication-title: Infect Immun
– volume: 54
  start-page: 369
  year: 2005
  end-page: 377
  ident: CR5
  article-title: Regulatory T cells in ovarian cancer: biology and therapeutic potential
  publication-title: Am J Reprod Immunol
  doi: 10.1111/j.1600-0897.2005.00330.x
– volume: 173
  start-page: 92
  year: 2004
  end-page: 99
  ident: CR15
  article-title: The third signal in T cell-mediated autoimmune disease?
  publication-title: J Immunol
– volume: 182
  start-page: 581
  year: 1995
  end-page: 586
  ident: CR14
  article-title: Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords
  publication-title: J Exp Med
  doi: 10.1084/jem.182.2.581
– volume: 32
  start-page: 3267
  year: 2002
  end-page: 3275
  ident: CR22
  article-title: Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1
– volume: 32
  start-page: 2133
  year: 2002
  end-page: 2144
  ident: CR2
  article-title: Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W
– volume: 54
  start-page: 669
  year: 2001
  end-page: 674
  ident: CR29
  article-title: Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.54.9.669
– volume: 9
  start-page: 4404
  year: 2003
  end-page: 4408
  ident: CR28
  article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers
  publication-title: Clin Cancer Res
– volume: 83
  start-page: 145
  year: 2007
  end-page: 152
  ident: CR18
  article-title: CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas
  publication-title: J Neurooncol
  doi: 10.1007/s11060-006-9314-y
– volume: 195
  start-page: 346
  year: 2003
  end-page: 355
  ident: CR21
  article-title: MHC class I antigens, immune surveillance, and tumor immune escape
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.10290
– volume: 178
  start-page: 6123
  year: 2007
  end-page: 6129
  ident: CR12
  article-title: Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells
  publication-title: J Immunol
– volume: 191
  start-page: 1605
  year: 2000
  end-page: 1610
  ident: CR25
  article-title: Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses
  publication-title: J Exp Med
  doi: 10.1084/jem.191.9.1605
– volume: 83
  start-page: 92
  year: 1984
  end-page: 100
  ident: CR38
  article-title: Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen
  publication-title: Cell Immunol
  doi: 10.1016/0008-8749(84)90228-4
– volume: 105
  start-page: 430
  year: 2006
  end-page: 437
  ident: CR19
  article-title: Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors
  publication-title: J Neurosurg
  doi: 10.3171/jns.2006.105.3.430
– volume: 34
  start-page: 2101
  year: 1998
  end-page: 2106
  ident: CR3
  article-title: Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(98)00244-5
– volume: 177
  start-page: 1552
  year: 2006
  end-page: 1560
  ident: CR9
  article-title: Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells
  publication-title: J Immunol
– volume: 10
  start-page: 95
  year: 2011
  end-page: 100
  ident: CR52
  article-title: Cellular immunologic response to primary cryoablation of C6 gliomas in rats
  publication-title: Technol Cancer Res Treat
– volume: 30
  start-page: 2422
  year: 2000
  end-page: 2431
  ident: CR45
  article-title: The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H
– volume: 32
  start-page: 3118
  year: 2002
  end-page: 3125
  ident: CR48
  article-title: Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B
– volume: 61
  start-page: 4766
  year: 2001
  end-page: 4772
  ident: CR50
  article-title: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
  publication-title: Cancer Res
– volume: 29
  start-page: 3269
  year: 2009
  end-page: 3279
  ident: CR46
  article-title: Prognostic impact of CD68 and kallikrein 6 in human glioma
  publication-title: Anticancer Res
– volume: 10
  start-page: 651
  year: 1998
  end-page: 662
  ident: CR43
  article-title: Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7–1, B7–2 and CD28
  publication-title: Int Immunol
  doi: 10.1093/intimm/10.5.651
– volume: 352
  start-page: 987
  year: 2005
  end-page: 996
  ident: CR47
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043330
– volume: 8
  start-page: 234
  year: 2006
  end-page: 243
  ident: CR17
  article-title: An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
  publication-title: Neuro Oncol
  doi: 10.1215/15228517-2006-006
– volume: 129
  start-page: 133
  year: 2002
  end-page: 140
  ident: CR1
  article-title: Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity
  publication-title: J Neuroimmunol
  doi: 10.1016/S0165-5728(02)00203-5
– volume: 74
  start-page: 9
  year: 2005
  end-page: 17
  ident: CR53
  article-title: An experimental study of dendritic cells mediated immunotherapy against intracranial gliomas in rats
  publication-title: J Neurooncol
– volume: 116
  start-page: 1837
  year: 2003
  end-page: 1846
  ident: CR7
  article-title: Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00378
– volume: 53
  start-page: 157
  year: 2000
  end-page: 162
  ident: CR35
  article-title: Brain tumors in Mexico: characteristics and prognosis of glioblastoma
  publication-title: Surg Neurol
  doi: 10.1016/S0090-3019(99)00177-9
– volume: 156
  start-page: 31
  year: 1982
  end-page: 40
  ident: CR33
  article-title: Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes
  publication-title: J Exp Med
  doi: 10.1084/jem.156.1.31
– volume: 169
  start-page: 2756
  year: 2002
  end-page: 2761
  ident: CR34
  article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
  publication-title: J Immunol
– volume: 36
  start-page: 671
  year: 2006
  end-page: 680
  ident: CR11
  article-title: Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200535353
– volume: 54
  start-page: 1153
  year: 2005
  end-page: 1161
  ident: CR10
  article-title: Regulatory T cells and tumor immunity
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-005-0699-9
– volume: 3
  start-page: 181
  year: 2001
  end-page: 188
  ident: CR37
  article-title: Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin
  publication-title: Cell Microbiol
  doi: 10.1046/j.1462-5822.2001.00106.x
– volume: 30
  start-page: 10
  year: 2003
  end-page: 14
  ident: CR8
  article-title: Factors influencing survival in high-grade gliomas
  publication-title: Semin Oncol
  doi: 10.1053/j.seminoncol.2003.11.031
– volume: 127
  start-page: 187
  year: 2003
  end-page: 192
  ident: CR49
  article-title: Clinical-histopathologic concordance of tumors of the nervous system at the Manuel Velasco Suarez National Institute of Neurology and Neurosurgery in Mexico City
  publication-title: Arch Pathol Lab Med
– volume: 46
  start-page: 511
  year: 1987
  end-page: 521
  ident: CR24
  article-title: Experimental autoimmune inflammatory myopathy
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-198709000-00001
– volume: 162
  start-page: 211
  year: 1982
  end-page: 220
  ident: CR32
  article-title: Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease
  publication-title: Immunobiology
  doi: 10.1016/S0171-2985(11)80001-X
– volume: 28
  start-page: 433
  year: 2008
  end-page: 440
  ident: CR41
  article-title: Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.159160
– volume: 44
  start-page: 91
  year: 1999
  ident: 1069_CR23
  publication-title: J Neurooncol
  doi: 10.1023/A:1006112422132
– volume: 129
  start-page: 133
  year: 2002
  ident: 1069_CR1
  publication-title: J Neuroimmunol
  doi: 10.1016/S0165-5728(02)00203-5
– volume: 59
  start-page: 4732
  year: 1991
  ident: 1069_CR39
  publication-title: Infect Immun
  doi: 10.1128/IAI.59.12.4732-4734.1991
– volume: 53
  start-page: 157
  year: 2000
  ident: 1069_CR35
  publication-title: Surg Neurol
  doi: 10.1016/S0090-3019(99)00177-9
– volume: 177
  start-page: 1552
  year: 2006
  ident: 1069_CR9
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.3.1552
– volume: 162
  start-page: 211
  year: 1982
  ident: 1069_CR32
  publication-title: Immunobiology
  doi: 10.1016/S0171-2985(11)80001-X
– volume: 170
  start-page: 1728
  year: 2003
  ident: 1069_CR27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.4.1728
– volume: 10
  start-page: 651
  year: 1998
  ident: 1069_CR43
  publication-title: Int Immunol
  doi: 10.1093/intimm/10.5.651
– volume: 178
  start-page: 6123
  year: 2007
  ident: 1069_CR12
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.10.6123
– volume: 20
  start-page: E1
  year: 2006
  ident: 1069_CR16
  publication-title: Neurosurg Focus
  doi: 10.3171/foc.2006.20.4.E1
– volume: 352
  start-page: 987
  year: 2005
  ident: 1069_CR47
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043330
– volume: 34
  start-page: 2101
  year: 1998
  ident: 1069_CR3
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(98)00244-5
– volume: 83
  start-page: 92
  year: 1984
  ident: 1069_CR38
  publication-title: Cell Immunol
  doi: 10.1016/0008-8749(84)90228-4
– volume: 28
  start-page: 433
  year: 2008
  ident: 1069_CR41
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.159160
– volume: 156
  start-page: 31
  year: 1982
  ident: 1069_CR33
  publication-title: J Exp Med
  doi: 10.1084/jem.156.1.31
– volume: 30
  start-page: 10
  year: 2003
  ident: 1069_CR8
  publication-title: Semin Oncol
  doi: 10.1053/j.seminoncol.2003.11.031
– volume: 191
  start-page: 1605
  year: 2000
  ident: 1069_CR25
  publication-title: J Exp Med
  doi: 10.1084/jem.191.9.1605
– volume: 130
  start-page: 2675
  year: 1983
  ident: 1069_CR30
  publication-title: J Immunol
  doi: 10.4049/jimmunol.130.6.2675
– volume: 3
  start-page: 181
  year: 2001
  ident: 1069_CR37
  publication-title: Cell Microbiol
  doi: 10.1046/j.1462-5822.2001.00106.x
– volume: 30
  start-page: 2422
  year: 2000
  ident: 1069_CR45
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H
– volume: 169
  start-page: 117
  year: 2002
  ident: 1069_CR26
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.1.117
– volume: 46
  start-page: 511
  year: 1987
  ident: 1069_CR24
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-198709000-00001
– volume: 54
  start-page: 1153
  year: 2005
  ident: 1069_CR10
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-005-0699-9
– volume: 173
  start-page: 92
  year: 2004
  ident: 1069_CR15
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.1.92
– volume: 24
  start-page: 575
  year: 2005
  ident: 1069_CR42
  publication-title: J Exp Clin Cancer Res
– volume: 54
  start-page: 369
  year: 2005
  ident: 1069_CR5
  publication-title: Am J Reprod Immunol
  doi: 10.1111/j.1600-0897.2005.00330.x
– volume: 32
  start-page: 155
  year: 2005
  ident: 1069_CR31
  publication-title: Immunol Res
  doi: 10.1385/IR:32:1-3:155
– volume: 83
  start-page: 145
  year: 2007
  ident: 1069_CR18
  publication-title: J Neurooncol
  doi: 10.1007/s11060-006-9314-y
– volume: 54
  start-page: 669
  year: 2001
  ident: 1069_CR29
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.54.9.669
– volume: 32
  start-page: 3118
  year: 2002
  ident: 1069_CR48
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B
– volume: 116
  start-page: 1837
  year: 2003
  ident: 1069_CR7
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00378
– volume: 32
  start-page: 2133
  year: 2002
  ident: 1069_CR2
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W
– volume: 32
  start-page: 3267
  year: 2002
  ident: 1069_CR22
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1
– ident: 1069_CR53
  doi: 10.1007/s11060-004-3339-x
– volume: 82
  start-page: 2637
  year: 1985
  ident: 1069_CR4
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.82.9.2637
– volume: 182
  start-page: 581
  year: 1995
  ident: 1069_CR14
  publication-title: J Exp Med
  doi: 10.1084/jem.182.2.581
– volume: 61
  start-page: 4766
  year: 2001
  ident: 1069_CR50
  publication-title: Cancer Res
– volume: 10
  start-page: 942
  year: 2004
  ident: 1069_CR13
  publication-title: Nat Med
  doi: 10.1038/nm1093
– ident: 1069_CR52
  doi: 10.7785/tcrt.2012.500183
– volume: 59
  start-page: 3128
  year: 1999
  ident: 1069_CR40
  publication-title: Cancer Res
– ident: 1069_CR51
  doi: 10.1007/BF00300234
– volume: 127
  start-page: 187
  year: 2003
  ident: 1069_CR49
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2003-127-187-CHCOTO
– volume: 105
  start-page: 430
  year: 2006
  ident: 1069_CR19
  publication-title: J Neurosurg
  doi: 10.3171/jns.2006.105.3.430
– volume: 36
  start-page: 671
  year: 2006
  ident: 1069_CR11
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200535353
– volume: 195
  start-page: 346
  year: 2003
  ident: 1069_CR21
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.10290
– volume: 8
  start-page: 234
  year: 2006
  ident: 1069_CR17
  publication-title: Neuro Oncol
  doi: 10.1215/15228517-2006-006
– volume: 163
  start-page: 5211
  year: 1999
  ident: 1069_CR44
  publication-title: J Immunol
  doi: 10.4049/jimmunol.163.10.5211
– volume: 66
  start-page: 3294
  year: 2006
  ident: 1069_CR20
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3773
– volume: 170
  start-page: 1504
  year: 2003
  ident: 1069_CR36
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.3.1504
– volume: 161
  start-page: 370
  year: 1968
  ident: 1069_CR6
  publication-title: Science
  doi: 10.1126/science.161.3839.370
– volume: 29
  start-page: 3269
  year: 2009
  ident: 1069_CR46
  publication-title: Anticancer Res
– volume: 9
  start-page: 4404
  year: 2003
  ident: 1069_CR28
  publication-title: Clin Cancer Res
– volume: 169
  start-page: 2756
  year: 2002
  ident: 1069_CR34
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.5.2756
SSID ssj0017572
Score 2.0517185
Snippet Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study...
In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to...
Purpose: In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 23
SubjectTerms Adjuvants
Animals
Antineoplastic agents
Apoptosis
Apoptosis - drug effects
Apoptosis - immunology
Biological and medical sciences
Blood
Brain cancer
Cancer Research
CD25 antigen
CD4 antigen
CD4-Positive T-Lymphocytes - drug effects
CD4-Positive T-Lymphocytes - immunology
Chemokine CCL3 - biosynthesis
Chemokine CCL3 - genetics
Chemokine CCL3 - immunology
Cytokines
Female
Foxp3 protein
Gene expression
Glioblastoma
Glioma - drug therapy
Glioma - immunology
Glioma - pathology
Glioma cells
Granzymes - biosynthesis
Granzymes - genetics
Granzymes - immunology
Hematology
Immune system
Immunologic Factors - immunology
Immunologic Factors - pharmacology
Immunomodulation
Immunosuppressive agents
Immunotherapy
Inflammation
Interleukin 6
Interleukin-2 Receptor alpha Subunit - immunology
Interleukin-6 - biosynthesis
Interleukin-6 - genetics
Interleukin-6 - immunology
Internal Medicine
Lymphocytes T
macrophage inflammatory protein 1
Macrophages - drug effects
Macrophages - immunology
Medical sciences
Medicine
Medicine & Public Health
Monocyte chemoattractant protein 1
Neurology
Oncology
Original Paper
Perforin
Perforin - biosynthesis
Perforin - genetics
Perforin - immunology
pertussis toxin
Pertussis Toxin - immunology
Pertussis Toxin - pharmacology
Pharmacology. Drug treatments
Prognosis
Rats
Rats, Wistar
Real-Time Polymerase Chain Reaction
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
Rodents
Spleen
Surgery
T-Lymphocytes, Regulatory - drug effects
T-Lymphocytes, Regulatory - immunology
Tumors of the nervous system. Phacomatoses
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9UwEB50BRFEvFtXlwg-KYUmbXN587C4LML65IF9K7lqZbc9bHvA8--d9LYc3RV8TtKEmaT5JjPzDcB7KT2iABdS3D5ooHi0UxR3LKWW0qCddyLEBOezr_x0XXw5L8-nPO5ujnafXZLDn3pJdhvY49IxBIurdHcX7pVousc4rjVbLa4DUQ4VmyIPDFpZlM-uzJs-sXcZPdzoDuUSxoIWNyHOvwMn__CeDpfSyWN4NKFJshrV_wTu-OYp3D-b_OXP4NPK_dwiVu5JHfNApmyrHWkDOebk-0XdXmpSNwS3QUfikyzZ-Kt-i-ekI337q26ew_rk87fj03SqmZDaMmd9iugkL42gymZWMRsKYQ3TZRa00sEoU5QuDz6SynufeZspLUQZDFot1DrpeP4CDpq28a-ACBPNMR-kdb4QQRnKuMlcZrWzZVAqgWwWXmUnQvFY1-KiWqiQB3lXKO8qyrvaJfBhGbIZ2TT-1floTyPLiMiahjgJF3A4q6iaTl5XKYqIiMs8T-Dd0opHJvpBdOPbbRenkzI-42QJkFv6xICEWIiFJfBy1Pn19FQVgnGZgNzbDUuHyNi939LUPwbm7mjNFTg8gY_zxrle-a2CeP1fvQ_hAYI6Nj4TvYGD_mrr3yJw6s3RcFB-AyggEWE
  priority: 102
  providerName: Springer Nature
Title Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin
URI https://link.springer.com/article/10.1007/s00432-011-1069-y
https://www.ncbi.nlm.nih.gov/pubmed/21947268
https://www.proquest.com/docview/913176833
https://www.proquest.com/docview/1008830420
https://www.proquest.com/docview/913446742
https://pubmed.ncbi.nlm.nih.gov/PMC11824194
Volume 138
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9RAEB-0BRGK1Gdj22MFPynBbJ67n_R6XC1Ki4gH56eQ7EMjNTmbHHj_vTN5lVPbLwlkd9nN7OzuvPY3AC-FMCgFaOsi-6CCYlBPkbH2Xa44t5k2OrF0wfn8Ij5bhB-W0bKPzan7sMphT2w3al0pspG_kRxPulgEwdvVL5eSRpFztc-gcRd2CbmMmDpZjvoWHoxt7iZChEF9i8eDU9PrMEQDikmgeK5YuputY2lvldVIIdultvif7PlvCOVfftT2eDrdhwe9XMmmHSM8hDumfAT3znvP-WN4N9U_1ig1N6ygGyH9vasNqyybxezbZVH9zFhRMmSImpFxlq3MVbPGFVOzpvpdlE9gcTr_Mjtz--wJrooCv3FRTgmiPOFSeUr6yoaJyv0s8mwmM5vLPIx0YA3ByxvjGeXJLEkim6P-wpUWOg6ewk5ZleYAWJKTYmasUNqEiZU59-Pc057KtIqslA54A_FS1UOLU4aLy3QERW7pnSK9U6J3unHg1dhk1eFq3FZ5sjUjYwvCT0OJCQdwOExR2q_BOh05xoEXYykuHvKIZKWp1jV1JwQZdDwH2A11KDSBUrL4Djzr5vy6ey7DxI-FA2KLG8YKhN29XVIW31sMb9LrQmzuwOuBca5HfiMhnt_6n4dwH8U5vzMQHcFOc7U2xygyNfmkXRj4FDM-gd3p-68f5_g-mV98-oxfF_70D0P8GO4
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9RADLZKkaASQpwlFMogwQsoYjI55wFBtVBtabdPrdS3kMwBQSVZmqxgfxT_ETtXtUD71ufM5PAR22P7M8CLJDHoBWjrovhggGIwTpGRFq6nPM9m2ujYUoPz7DCaHgefTsKTNfg99MJQWeXwT2x_1LpSdEb-Rnpo6aLE99_Nf7g0NIqSq8MEjU4q9s3yJ0Zs9du9D8jel0LsfjyaTN1-qICrQl80LppvP8xjTyqupFA2iFUuspDbTGY2l3kQat8aQl03hhvFZRbHoc3RrfeUTnTk432vwfXAR82kxvTJWFGChridFUUINBjfedGQROUdZqlPNRBUPxZJd7liBm_Nsxo5YrtRGv_zdf8t2fwrb9uaw907cLv3Y9lOJ3h3Yc2U9-DGrM_U34f3O_rbAr30hhXUgdL3eS1ZZdkkYl9Oi-p7xoqSoQDWjA6D2dycNQvU0Jo11a-ifADHV0LYh7BeVqV5BCzOKRA0NlHaBLGVuSeinGuuMq1CK6UDfCBeqnooc5qocZqOIMwtvVOkd0r0TpcOvBq3zDscj8sWb69wZNxBeG3ooeELbA0sSnudr9NRQh14Pl5FZaUMTFaaalHT45KEDpC4A-yCNVQKQSNghAObHc_PH-_JIBZR4kCyIg3jAsIKX71SFl9bzHCKIwPc7sDrQXDO3_xCQjy-9Dufwc3p0ewgPdg73N-CDXQlRXc49QTWm7OFeYruWpNvt0rC4PNVa-UfHXFRwQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9VAEJ4gJsSEGK9QUVwTfdE0tNvb7oNRcvAERIgPkvBW271oDbZH2hM9P81_50xv5KjwxvPuttu5dGZ2Zr8BeC6EQS9AWxfFBwMUg3GKjDV3feX7NtNGJ5YuOB8dx_sn4fvT6HQFfg93Yaiscvgntj9qXSk6I9-RPlq6WATBju2rIj7uTd_MfrjUQIoSrUM3jU5CDs3iJ0Zv9euDPWT1C86n7z5N9t2-wYCrooA3LpryIMoTXypPSa5smKicZ5FnM5nZXOZhpANrCIHdGM8oT2ZJEtkcXXxfaaHjAJ97A24mQSJIxcRkrC5Bo9z2jSI0Goz1_HhIqHodfmlA9RBUSxZLd7FkEtdnWY3csV1bjf_5vf-Wb_6Vw21N4_QO3O59WrbbCeFdWDHlPVg76rP29-Htrv42R4-9YQXdRunvfC1YZdkkZl_Oiup7xoqSoTDWjA6G2cycN3PU1po11a-ifAAn10LYh7BaVqXZBJbkFBQaK5Q2YWJl7vM497SnMq0iK6UD3kC8VPWw5tRd4ywdAZlbeqdI75TonS4ceDkumXWYHldN3l7iyLiCsNvQW8MNbA0sSnv9r9NRWh14No6i4lI2JitNNa_pdULQYZLnALtkDpVFUDsY7sBGx_OL1_syTHgsHBBL0jBOINzw5ZGy-Nrih1NMGeJyB14NgnOx80sJ8ejK73wKa6iP6YeD48MtuIVeJe_OqR7DanM-N0_Qc2vy7VZHGHy-bqX8A9-ZVfc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adjuvant+immunotherapy+of+C6+glioma+in+rats+with+pertussis+toxin&rft.jtitle=Journal+of+cancer+research+and+clinical+oncology&rft.au=OROZCO-MORALES%2C+Mario&rft.au=SANCHEZ-GARCIA%2C+Francisco-Javier&rft.au=GUEVARA-SALAZAR%2C+Patricia&rft.au=ARRIETA%2C+Oscar&rft.date=2012-01-01&rft.pub=Springer&rft.issn=0171-5216&rft.volume=138&rft.issue=1&rft.spage=23&rft.epage=33&rft_id=info:doi/10.1007%2Fs00432-011-1069-y&rft.externalDBID=n%2Fa&rft.externalDocID=25566359
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0171-5216&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0171-5216&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0171-5216&client=summon